Determination of protamine peptides in insulin drug products using reversed phase high performance liquid chromatography

Journal of Pharmaceutical and Biomedical Analysis

Volumn 37, Issue 3, 2005, Pages 551-557

  Hvass, A ^a   Skelbaek Pedersen, B ^a  

^a NOVO NORDISK A S   (Denmark)

Author keywords

Insulin drug products; Protamine peptides; Protamine sulphate; Reversed phase HPLC

Indexed keywords

INSULIN; PEPTIDE; PROTAMINE SULFATE;

ARTICLE; DRUG FORMULATION; PRIORITY JOURNAL; QUALITY CONTROL; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; VALIDATION PROCESS;

EID: 14644400409     PISSN: 07317085     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpba.2004.11.028     Document Type: Article

References (8)

1. J. Brange Galenics of Insulin 1987 Springer-Verlag Berlin
2. T. Ando, M. Yamasaki, and K. Suzuki Protamines, Isolation, Characterization Structure and Function 1973 Springer-Verlag Berlin
3. J.A. Hoffmann, R.E. Chance, and M.G. Johnson Prot. Exp. Purif. 1 1990 127 133
4. C. Rolim, and A.F. Bristow Pharmeuropa 7.4 1995 595 598
5. Insulin Injection, Biphasic Isophane, 4th ed., 4.05, Monograph 01/2002:0832, European Pharmacopoeia.
6. A. Snycerski, J. Dudkiewicz-Wilczynska, and J. Tautt J. Pharm. Biomed. Anal. 18 1998 907 910
7. J. Brange Stability of Insulin 1994 Kluwer Academic Publishers Boston
8. Insulin Preparations, Injectable, 4th ed., 4.05, Monograph 01/2002:0854, European Pharmacopoeia, 2002.